Validation of a multivariate model predicting presence and size of varices

Journal of Clinical Gastroenterology

Volumn 41, Issue 6, 2007, Pages 609-615

  Burton Jr , James R ^a   Liangpunsakul, Suthat ^b   Lapidus, Jodi ^c   Giannini, Edoardo ^d   Chalasani, Naga ^b   Zaman, Atif ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b INDIANA UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Cirrhosis; Screening; Varices

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STOMACH VARICES; THROMBOCYTE COUNT; VALIDATION PROCESS;

ADULT; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FORECASTING; HUMANS; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET COUNT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34250723827     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225669.84099.04     Document Type: Article

References (20)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension. A meta-analytic review. Hepatology. 1995;22:332-354.
2. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000; 33:846-852.
3. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med. 1988;319:983-989.
4. Jenson DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122:1620-1630.
5. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol. 1997;92:1081-1091.
6. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-176.
7. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868-880.
8. Spiegel BMR, Targownik L, Dulai GS, et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost effective? Hepatology. 2003;37:366-377.
9. Arguedas MR, Heudebert GR, Eloubeidi MA, et al. Cost-effectiveness of screening, surveillance and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol. 2002;97: 2441-2452.
10. Jutabha R, Jenson DM, Martin P, et al. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology. 2005;128:1120-1122.
11. Davis GL, Albrigth JE, Cook SF, et al. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;4:331-338.
12. Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161:2564-2570.
13. Madhotra R, Mulcahy HE, Willner I, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34: 81-85.
14. Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999;94:3285-3291.
15. Giannini EG, Botta F, Borro P, et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on followup. Dig Dis Sci. 2005;37:779-785.
16. Saab S, DeRosa V, Nieto J, et al. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastro. 2003;98: 763-770.
17. Merkel C, Marin R, Angeli P, et al. A placebo-controlled clinical trial of nadolol in prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004;127: 476-484.
18. Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254-2261.
19. Calès P, Desmorat H, Vinel JP, et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut. 1990;31:1298-1302.
20. Ramirez FC, Hakim S, Tharalson EM, et al. Feasibility and safety of string wireless capsule endoscopy in the diagnosis of esophageal varices. Am J Gastroenterol. 2005;100:1065-1071.